Javascript must be enabled to continue!
Effectiveness of Pain Self-Management Support Intervention on Pain and Its Interference with Daily Activities among Patients with Cancer in Vinh Phuc Province
View through CrossRef
Objective: This study was carried out to evaluate the effectiveness of pain self-management support intervention on pain and its interference with daily activities among patients with cancer in Vinh Phuc Province after 1 week of discharge from the hospital.
Methods: A randomized controlled clinical trial was used. The study was conducted on 116 patients with cancer with pain treated at Vinh Phuc Provincial General Hospital. The pain self-management support intervention for patients with cancer through health education consultation is carried out 1 week before the patient leaves the hospital until 01 week after discharge. Intervention content includes providing information about pain, building pain management skills, and supporting patients with cancer with self-care. Patients completed the questionnaire before implementing the program and 01 week after discharge. The research period is from February 2023 to the end of July 2023. Data were analyzed using SPSS 20.0 using descriptive statistics algorithms, parametric and non-parametric tests.
Results: In the intervention group, there was a statistically significant difference in the average score before intervention and after 1 week of discharge in worst pain (4.88 ± 1.55 and 3.64 ± 1.45, p < 0.05), mildest pain (2.14 ± 1.05 and 1.68 ± 0.92, p<0.05), moderate pain (3.54 ± 1.39 and 2.38 ± 1.04, p<0, 05), current pain (3.09 ± 1.76 and 2.25 ± 1.25, p<0.05), general pain (3.41 ± 1.28 and 2.49 ± 1.07, p <0.05), pain interference on daily activities (4.23 ± 1.75 and 3.48 ± 1.91, p <0.05). The study also showed that there was a statistically significant difference in the average score between the intervention group and the control group at 1 week of discharge in worst pain (3.64 ± 1.45 and 5.00). ± 1.71, p<0.05), moderate pain (2.38 ± 1.04 and 3.46 ± 1.61, p<0.05), current pain (2.25 ± 1.25 and 3.31 ± 1.88, p < 0.05), general pain (2.49 ± 1.07 and 3.50 ± 1.52, p < 0.05), pain interference on daily activities days (3.48 ± 1, 91 and 4.35 ± 2.18, p<0.05). The influence coefficient for general pain intensity is moderate (Cohen's d = 0.76), and the influence coefficient for the influence of pain on daily activities is small (Cohen'sd = 0.42).
Conclusions: The pain self-management support intervention for patients with cancer through health education consultation has been effective in reducing pain and reducing pain interference with daily activities in patients with cancer. In caring for patients with cancer, it is recommended to strengthen health education and counseling on pain management for them so that they can self-manage pain and contribute to controlling their pain.
Title: Effectiveness of Pain Self-Management Support Intervention on Pain and Its Interference with Daily Activities among Patients with Cancer in Vinh Phuc Province
Description:
Objective: This study was carried out to evaluate the effectiveness of pain self-management support intervention on pain and its interference with daily activities among patients with cancer in Vinh Phuc Province after 1 week of discharge from the hospital.
Methods: A randomized controlled clinical trial was used.
The study was conducted on 116 patients with cancer with pain treated at Vinh Phuc Provincial General Hospital.
The pain self-management support intervention for patients with cancer through health education consultation is carried out 1 week before the patient leaves the hospital until 01 week after discharge.
Intervention content includes providing information about pain, building pain management skills, and supporting patients with cancer with self-care.
Patients completed the questionnaire before implementing the program and 01 week after discharge.
The research period is from February 2023 to the end of July 2023.
Data were analyzed using SPSS 20.
0 using descriptive statistics algorithms, parametric and non-parametric tests.
Results: In the intervention group, there was a statistically significant difference in the average score before intervention and after 1 week of discharge in worst pain (4.
88 ± 1.
55 and 3.
64 ± 1.
45, p < 0.
05), mildest pain (2.
14 ± 1.
05 and 1.
68 ± 0.
92, p<0.
05), moderate pain (3.
54 ± 1.
39 and 2.
38 ± 1.
04, p<0, 05), current pain (3.
09 ± 1.
76 and 2.
25 ± 1.
25, p<0.
05), general pain (3.
41 ± 1.
28 and 2.
49 ± 1.
07, p <0.
05), pain interference on daily activities (4.
23 ± 1.
75 and 3.
48 ± 1.
91, p <0.
05).
The study also showed that there was a statistically significant difference in the average score between the intervention group and the control group at 1 week of discharge in worst pain (3.
64 ± 1.
45 and 5.
00).
± 1.
71, p<0.
05), moderate pain (2.
38 ± 1.
04 and 3.
46 ± 1.
61, p<0.
05), current pain (2.
25 ± 1.
25 and 3.
31 ± 1.
88, p < 0.
05), general pain (2.
49 ± 1.
07 and 3.
50 ± 1.
52, p < 0.
05), pain interference on daily activities days (3.
48 ± 1, 91 and 4.
35 ± 2.
18, p<0.
05).
The influence coefficient for general pain intensity is moderate (Cohen's d = 0.
76), and the influence coefficient for the influence of pain on daily activities is small (Cohen'sd = 0.
42).
Conclusions: The pain self-management support intervention for patients with cancer through health education consultation has been effective in reducing pain and reducing pain interference with daily activities in patients with cancer.
In caring for patients with cancer, it is recommended to strengthen health education and counseling on pain management for them so that they can self-manage pain and contribute to controlling their pain.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Abstract
Thoracic outlet syndrome (TOS) is a complex and often overlooked condition caused by the compression of neurovascular structures as they pass through the thoracic outlet. ...
Exploring the Efficacy of Once and Twice Weekly Thyroxine Dosing: A Promising Approach for Hypothyroidism Management
Exploring the Efficacy of Once and Twice Weekly Thyroxine Dosing: A Promising Approach for Hypothyroidism Management
Abstract
Introduction
Hypothyroidism is a common endocrine disorder, in which the management involves daily intake of thyroxine. However, adherence to a daily medication regimen po...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

